A decreased capacity for the synthesis of a globin chain results in clinical conditions known as thalassemias. Beta thalassemia is characterised by an increase in haemoglobin A2. Alpha thalassemia is characterized by a decrease in hemoglobin A2 and delta-beta thalassemia is characterised by an increase in hemoglobin F. Accurate quantitation of haemoglobins A2 and F is required for the evaluation of these conditions.
High performance liquid chromatographic (HPLC) methods with high sensitivity and specificity have been developed for hemoglobin fractionation. Trinity Biotech’s ultra2 Resolution system for the separation and quantitation of normal and variant hemoglobin species in blood is designed to provide the maximum amount of information in the shortest possible time. This method combines the sensitivity and specificity of HPLC with sample preparation automation and assistance in evaluating the result.
The user friendly software for the ultra2 is a Windows XP™ based program especially designed for haemoglobin variant analysis.
As the sample is chromatographed, it is displayed on the monitor in real time.
The computer produces printed reports with the sample identification information, date and time, followed by the chromatogram with retention times indicated at the apex of each peak.
A peak summary report is printed after the chromatogram with the retention time, relative retention time, % area and comments for each peak in the chromatogram.
Barcode reading – positive sample ID from specimen to end result Automated – walk-away, cost-effective operation Selectable Test Methods:
Relative retention times: 0.001 minutes Hb measurement starts at time zero: